Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02641184
Recruitment Status : Unknown
Verified February 2016 by Xiao Ye, MD, Zhejiang Provincial People’s Hospital. Recruitment status was: Enrolling by invitation
First Posted : December 29, 2015
Last Update Posted : February 17, 2016
Zhejiang Provincial People’s Hospital
Yangzhou No.1 People's Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Huaian first people's hospital
Information provided by (Responsible Party):
Xiao Ye, MD, Zhejiang Provincial People’s Hospital
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients presenting to an emergency room and diagnosed as acute myocardial infarction
Less than 12 hours after the onset of myocardial infarction symptoms
Myocardial necrosis, as evidenced by increased Creatine Kinase Isoenzyme (CK-MB) or troponin levels